UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		184,135,714
Beginning balance at Dec. 31, 2022	$ 5,230	$ 2	$ 1,562,247	$ 6	$ (1,557,025)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from sale of stock under employee stock purchase plan (in shares)		103,500
Proceeds from sale of stock under    employee stock purchase plan	34		34
Stock-based compensation expense	2,489		2,489
Restricted stock unit vesting (in shares)		1,596,732
Net income (loss)	(26,876)				(26,876)
Ending balance (in shares) at Mar. 31, 2023		185,835,946
Ending balance at Mar. 31, 2023	(19,123)	$ 2	1,564,770	6	(1,583,901)
Beginning balance (in shares) at Dec. 31, 2022		184,135,714
Beginning balance at Dec. 31, 2022	5,230	$ 2	1,562,247	6	(1,557,025)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(38,050)
Ending balance (in shares) at Jun. 30, 2023		188,128,869
Ending balance at Jun. 30, 2023	(26,805)	$ 2	1,568,260	6	(1,595,073)
Beginning balance (in shares) at Mar. 31, 2023		185,835,946
Beginning balance at Mar. 31, 2023	(19,123)	$ 2	1,564,770	6	(1,583,901)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	3,490		3,490
Restricted stock unit vesting (in shares)		2,292,923
Net income (loss)	(11,172)				(11,172)
Ending balance (in shares) at Jun. 30, 2023		188,128,869
Ending balance at Jun. 30, 2023	$ (26,805)	$ 2	1,568,260	6	(1,595,073)
Beginning balance (in shares) at Dec. 31, 2023	194,582,539	194,582,539
Beginning balance at Dec. 31, 2023	$ (30,584)	$ 2	1,578,358	6	(1,608,950)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)		13,261,311
Issuance of common stock, net of    issuance costs	18,740		18,740
Proceeds from sale of stock under employee stock purchase plan (in shares)		92,321
Proceeds from sale of stock under    employee stock purchase plan	70		70
Exercise of options (in shares)		280,260
Exercise of options	141		141
Stock-based compensation expense	2,360		2,360
Restricted stock unit vesting (in shares)		1,237,718
Net income (loss)	(17,985)				(17,985)
Ending balance (in shares) at Mar. 31, 2024		209,454,149
Ending balance at Mar. 31, 2024	$ (27,258)	$ 2	1,599,669	6	(1,626,935)
Beginning balance (in shares) at Dec. 31, 2023	194,582,539	194,582,539
Beginning balance at Dec. 31, 2023	$ (30,584)	$ 2	1,578,358	6	(1,608,950)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of options (in shares)	304,152
Net income (loss)	$ (26,567)
Ending balance (in shares) at Jun. 30, 2024	209,929,145	209,929,145
Ending balance at Jun. 30, 2024	$ (33,754)	$ 2	1,601,755	6	(1,635,517)
Beginning balance (in shares) at Mar. 31, 2024		209,454,149
Beginning balance at Mar. 31, 2024	(27,258)	$ 2	1,599,669	6	(1,626,935)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of options (in shares)		23,892
Exercise of options	14		14
Stock-based compensation expense	2,072		2,072
Restricted stock unit vesting (in shares)		451,104
Net income (loss)	$ (8,582)				(8,582)
Ending balance (in shares) at Jun. 30, 2024	209,929,145	209,929,145
Ending balance at Jun. 30, 2024	$ (33,754)	$ 2	$ 1,601,755	$ 6	$ (1,635,517)